Back to Agenda
Dare to Be Different: Comparing Biosensor Data to Patient-Reported Outcomes Data - Learnings from Asthma
Session Chair(s)
Alison Greene
Genentech, A Member of the Roche Group, United States
A study of asthma patients compared data collected by wearable-device and “usual” self-reported diary format. Session topics include: Lessons learned, implications for clinical trial design, and wider landscape of biosensors in clinical studies.
Learning Objective : Discuss the context and considerations for including biosensors in drug development trials; Manage the technical issues for successful implementation in a study; Describe the current landscape and status of biosensor use in clinical studies.
Speaker(s)
Rethinking Outcomes Assessments: Where Do Biosensors Fit in Drug Development?
Alison Greene
Genentech, A Member of the Roche Group, United States
Implementing New Technology in Clinical Trials: An Interesting Adventure
John Reites
THREAD, United States
Chief Executive Officer
Have an account?